Skip to main content
. Author manuscript; available in PMC: 2013 Oct 22.
Published in final edited form as: Int J Tuberc Lung Dis. 2011 Feb;15(2):257–i.

Table 2.

Risk factors for death prior to and during TB treatment among TB patients in North Carolina

Characteristic Death prior to
TB treatment
OR (95%CI)
Death early
(first 8 weeks)
in TB treatment
HR (95%CI)
Death late
(8–26 weeks)
in TB treatment
HR (95%CI)
Age
 Per year increase 1.04 (1.03–1.05)* 1.06 (1.05–1.07)* 1.05 (1.04–1.07)*
 Per decade increase 1.48 (1.34–1.63)* 1.79 (1.63–1.97)* 1.63 (1.48–1.88)*
Race and HIV status
 Non-Hispanic White, HIV− Referent Referent Referent
 Non-Hispanic White, HIV+ 4.11 (1.04–16.34)* 2.77 (0.85–9.05) 2.93 (0.47–18.50)
 Non-Hispanic Black, HIV− 1.16 (0.81–1.65) 1.38 (1.06–1.78)* 1.17 (0.82–1.67)
 Non-Hispanic Black, HIV+ 3.00 (1.56–5.77)* 2.08 (1.17–3.71)* 5.79 (3.20–10.48)*
 Hispanic, HIV− 1.33 (0.56–3.16) 1.30 (0.58–2.91) 0.56 (0.13–2.39)
 Hispanic, HIV+ 1.80 (0.35–9.21) Undefined 1.71 (0.19–15.32)
 Asian, HIV− 0.53 (0.16–1.73) 0.75 (0.30–1.85) 0.42 (0.10–1.72)
 Native American, HIV− 3.35 (1.12–10.03)* 1.92 (0.70–5.27) 0.97 (0.13–7.05)
Sex
 Male Referent Referent Referent
 Female 1.03 (0.75–1.43) 0.86 (0.67–1.10) 0.92 (0.66–1.28)
Excess alcohol use 0.90 (0.54–1.50) 1.62 (1.13–2.32)* 0.77 (0.44–1.34)
Injection drug use 2.39 (0.73–7.81) 1.80 (0.71–4.55) 1.60 (0.57–4.47)
Non-injection drug use 0.43 (0.17–1.08) 0.67 (0.36–1.26) 1.13 (0.54–2.34)
Homeless 1.08 (0.51–2.29) 1.24 (0.73–2.12) 0.83 (0.38–1.81)
Nursing home resident 1.41 (0.86–2.30) 1.65 (1.20–2.29)* 1.41 (0.85–2.32)
Disease site
 Pulmonary Referent Referent Referent
 Miliary/meningeal 2.36 (1.28–4.34)* 1.93 (1.18–3.17)* 2.07 (1.07–3.98)*
 Extra-pulmonary (not miliary/meningeal) 0.91 (0.59–1.38) 0.62 (0.43–0.89)* 1.23 (0.83–1.81)
*

Statistically significant.

TB = tuberculosis; OR = odds ratio; CI = confidence interval; HR = hazards ratio; HIV = human immunodeficiency virus; HIV− = HIV−negative; HIV+ = HIV−positive.